Related references
Note: Only part of the references are listed.Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays
Katrine L. Henriksen et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies
HM Nielsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
HER2 and responsiveness of breast cancer to adjuvant chemotherapy
KI Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
HER-2 testing in breast cancer using parallel tissue-based methods
H Yaziji et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma
R Bhargava et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2004)
Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays
DH Zhang et al.
HUMAN PATHOLOGY (2003)
The prognostic relevance of estimates of proliferative activity in early breast cancer
BV Offersen et al.
HISTOPATHOLOGY (2003)
Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer
DH Zhang et al.
MODERN PATHOLOGY (2003)
Tissue microarrays for rapid linking of molecular changes to clinical endpoints
J Torhorst et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Validation of tissue microarray technology in breast carcinoma
RL Camp et al.
LABORATORY INVESTIGATION (2000)
HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma
MP Hoang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
